http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#Head http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#assertion http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#provenance http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#pubinfo http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#assertion http://purl.obolibrary.org/obo/DOID_0050782 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_0050782 http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00927 http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association http://www.w3.org/2000/01/rdf-schema#label famotidine is indicated in most adult patients heal within 4 weeks there is rarely reason to use famotidine at full dosage for longer than 6 to 8 weeks studies have not assessed the safety of famotidine in uncomplicated active duodenal ulcer for periods of more than eight weeks short term treatment of active duodenal ulcer controlled studies in adults have not extended beyond one year maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer most adult patients heal within 6 weeks studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks short term treatment of active benign gastric ulcer famotidine is indicated for short term treatment of patients with symptoms of gerd see famotidine is also indicated for the short term treatment of esophagitis due to gerd including erosive or ulcerative disease diagnosed by endoscopy see short term treatment of gastroesophageal reflux disease gerd clinical pharmacology in adults clinical studies clinical pharmacology in adults clinical studies treatment of pathological hypersecretory conditions e g zollinger ellison syndrome multiple endocrine adenomas see clinical pharmacology in adults clinical studies http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00927 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#provenance http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#pubinfo http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#sig http://purl.org/nanopub/x/hasSignature JL/aI0TC2nGppPtS4NAMiPVhiBBKz0kOl8OjGxa5VoUn209dUeTlqm1EsaBj/IGDjb4AoIF0sVUGIbsjaqaMywK9Asdarh9VarMOKCQhMO6VPN60hKLOc33JHr65q6G6j6wDacHIF0gascjZLU5UqGJV82LU9SiThSs9Do+qGrU= http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI http://purl.org/dc/terms/created 2021-06-18T08:33:32.463+02:00 http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAV022RragZA9VErCVMTzjVtGjn90GbAjAIj7E4N-_wUI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs